Evidence map›Paper›PMID 30291105›Full record

ArticleCancer research2019

Implications of Epigenetic Drift in Colorectal Neoplasia.

Georg E Luebeck, William D Hazelton, Kit Curtius, Sean K Maden, Ming Yu, Kelly T Carter, Wynn Burke, Paul D Lampe, Christopher I Li, Cornelia M Ulrich and 6 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02328677 (ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02328677 recruitingnot on this map

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis

TypeobservationalSponsorUniversity of UtahRan2007 to 2030Enrolled5,000ConditionsColorectal Cancer
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  7. Making sense of the ageing methylome.Nature reviews. Genetics · 2022
    Review
  8. Review
  9. Gut · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. The ColoCare Study: A Paradigm of Transdisciplinary Science in Colorectal Cancer Outcomes.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019
    Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Georg E LuebeckProgram in Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. gluebeck@fredhutch.org hazelton@fredhutch.org.
William D HazeltonProgram in Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. gluebeck@fredhutch.org hazelton@fredhutch.org.
Kit CurtiusCentre for Tumour Biology, Barts Cancer Institute, London, United Kingdom.ORCID 0000-0002-2678-0960
Sean K MadenClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Ming YuClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Kelly T CarterClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0003-1772-9431
Wynn BurkeDivision of Gastroenterology, Department of Medicine, University of Washington, Seattle, Washington.ORCID 0000-0002-0165-6154
Paul D LampeMolecular Diagnostics, Public Health and Human Biology Divisions, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0002-1399-2761
Christopher I LiTranslational Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Cornelia M UlrichHuntsman Cancer Institute and Department of Population Health Sciences, University of Utah, Salt Lake City, Utah.
Polly A NewcombEpidemiology, School of Public Health, University of Washington, Seattle, Washington.
Maria WesterhoffDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.
Andrew M KazClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Yanxin LuoDepartment of Colorectal Surgery, the Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou China.
John M InadomiDivision of Gastroenterology, Department of Medicine, University of Washington, Seattle, Washington.ORCID 0000-0001-6776-8661
William M GradyClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0002-0129-7809
Fred Hutch Cancer Center · USUniversity of Washington · USSeattle Cancer Care Alliance · USCancer Research UK · GBHuntsman Cancer Institute · USSun Yat-sen University · CNUniversity of Michigan · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
Tumor mutation signaturesP01CA077852 · NCI · UNIVERSITY OF WASHINGTON · PI SHMULEVICH, ILYA · 1999 to 2019
$26.0M
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare StudyU01CA206110 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jane C. Figueiredo, Christopher I Li · 2016 to 2026
$18.6M
Trans-NetworkU54CA143862 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MELDRUM, DEIRDRE R. · 2009 to 2013
$8.4M
The Colon Cancer Family Registry: SeattleU24CA074794 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 2008 to 2011
$7.0M
Identify and validate novel epigenetic molecular markers for colorectal neoplasmU01CA152756 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY, GUDA, KISHORE · 2010 to 2021
$6.7M
Controlling Esophageal Cancer: A Collaborative Modeling ApproachU01CA199336 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HUR, CHIN, INADOMI, JOHN MATTHEW · 2015 to 2019
$5.9M
Discovery and verification of novel biomarkers of colorectal cancer recurrenceR01CA189184 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LI, CHRISTOPHER I, ULRICH, CORNELIA M · 2015 to 2020
$5.6M
Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer RecurrenceR01CA207371 · NCI · UNIVERSITY OF UTAH · PI LI, CHRISTOPHER I, ULRICH, CORNELIA M · 2017 to 2022
$3.9M
NSAID and COX/PG Metabolism and Colorectal CancerR01CA112516 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ULRICH, CORNELIA M · 2005 to 2009
$3.6M
Esophageal Cancer from Cells to Population: A Multiscale ApproachU01CA182940 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HUR, CHIN, INADOMI, JOHN MATTHEW · 2013 to 2017
$3.3M
Medical Research Council MR/S003851/1NCI NIH HHS P01 CA077852NCI NIH HHS P30 CA015704NCI NIH HHS P30 CA042014NCI NIH HHS R01 CA112516NCI NIH HHS R01 CA114467NCI NIH HHS R01 CA120523NCI NIH HHS R01 CA189184NCI NIH HHS R01 CA194663NCI NIH HHS R01 CA207371NCI NIH HHS R01 CA220004NCI NIH HHS R03 CA165153NCI NIH HHS R50 CA233042NCI NIH HHS U01 CA152756NCI NIH HHS U01 CA182940NCI NIH HHS U01 CA199336NCI NIH HHS U01 CA206110NCI NIH HHS U24 CA074794NCI NIH HHS U54 CA143862NIDDK NIH HHS K24 DK080941
6 · The paper itself

Abstract

Many normal tissues undergo age-related drift in DNA methylation, providing a quantitative measure of tissue age. Here, we identify and validate 781 CpG islands (CGI) that undergo significant methylomic drift in 232 normal colorectal tissues and show that these CGI continue to drift in neoplasia while retaining significant correlations across samples. However, compared with normal colon, this drift advanced (∼3-4-fold) faster in neoplasia, consistent with increased cell proliferation during neoplastic progression. The observed drift patterns were broadly consistent with modeled adenoma-to-carcinoma sojourn time distributions from colorectal cancer incidence data. These results support the hypothesis that, beginning with the founder premalignant cell, cancer precursors frequently sojourn for decades before turning into cancer, implying that the founder cell typically arises early in life. At least 77% to 89% of the observed drift variance in distal and rectal tumors was explained by stochastic variability associated with neoplastic progression, whereas only 55% of the variance was explained for proximal tumors. However, gene-CGI pairs in the proximal colon that underwent drift were significantly and primarily negatively correlated with cancer gene expression, suggesting that methylomic drift participates in the clonal evolution of colorectal cancer. Methylomic drift advanced in colorectal neoplasia, consistent with extended sojourn time distributions, which accounts for a significant fraction of epigenetic heterogeneity in colorectal cancer. Importantly, these estimated long-duration premalignant sojourn times suggest that early dietary and lifestyle interventions may be more effective than later changes in reducing colorectal cancer incidence. SIGNIFICANCE: These findings present age-related methylomic drift in colorectal neoplasia as evidence that premalignant cells can persist for decades before becoming cancerous.

Indexed as

DNA MethylationAdultAgedAged, 80 and overAge FactorsColorectal NeoplasmsCpG IslandsEpigenesis, GeneticGene ExpressionHumansMiddle AgedModels, GeneticStochastic ProcessesYoung Adult

Identifiers

PMID30291105
PMCPMC6359943
OpenAlexW2894974194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.